Pharmaceuticals

Personalized Medicine Fueling Growth In The Biologics Is Supporting Expansion In The Menopausal Disorder Treatment Market

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Menopausal Disorder Treatment Market Projected To Reach By 2030?

The menopausal disorder treatment market size has seen substantial growth over recent years. It is anticipated to increase from $11.47 billion in 2025 to $12.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. The historical expansion of this market can be attributed to factors such as a growing aging female population, the widespread application of hormone replacement therapy, a greater diagnosis of menopausal symptoms, the expansion of gynecology care services, and increasing healthcare access for women.

The menopausal disorder treatment market size is anticipated to undergo significant expansion in the upcoming years. It is projected to achieve a valuation of $16.26 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This growth over the forecast period is attributable to factors such as growth in demand for safer menopause treatments, an increasing focus on individualized therapy plans, rising awareness of long-term hrt risks, the expansion of digital women’s health platforms, and the growing adoption of preventive women’s healthcare. Key trends shaping the forecast period include a rising preference for non-hormonal menopause therapies, increasing adoption of personalized hormone replacement therapy, a growing use of lifestyle and behavioral interventions, the expansion of herbal and natural menopause treatments, and increasing awareness of menopause symptom management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24318&type=smp

Which Important Drivers Are Guiding The Menopausal Disorder Treatment Market Growth?

The increasing demand for hormone replacement therapies (HRT) is anticipated to drive the expansion of the menopausal disorder treatment market in the future. HRT refers to a medical intervention involving the supplementation or replacement of hormones to alleviate symptoms linked to menopause or hormonal imbalances. The surge in hormone replacement therapies is fueled by growing awareness and the need for effective management of menopausal symptoms and hormonal fluctuations. HRT addresses menopausal disorders by directly replenishing estrogen and progesterone levels, thereby helping to restore hormonal balance and relieve disruptive symptoms such as hot flashes, night sweats, and mood swings, ultimately enhancing quality of life. For instance, in October 2024, the NHS Business Services Authority (NHSBSA), a UK-based organization providing various support services, reported that the number of HRT items prescribed increased by 22% to 13 million, alongside a 12% rise in identified patients, from 2.3 million in 2022/23 to 2.6 million in 2023/24. Consequently, the escalating demand for hormone replacement therapies is a primary driver for the growth of the menopausal disorder treatment market.

How Are Segments Identified Within The Menopausal Disorder Treatment Market Segment Framework?

The menopausal disorder treatment market covered in this report is segmented –

1) By Treatment Type: Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications

2) By Stages: Menopause, Postmenopause, Perimenopause

3) By Application: Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Hormone Replacement Therapy (HRT): Estrogen Therapy, Progesterone Therapy, Combination Therapy, Transdermal Patches, Vaginal Estrogen, Oral Tablets

2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs), Antidepressants, Gabapentin, Clonidine, Bisphosphonates, Calcium And Vitamin D Supplements

3) By Herbal Supplements: Black Cohosh, Red Clover, Dong Quai, Ginseng, Soy Isoflavones, Flaxseed

4) By Lifestyle Modifications: Dietary Changes, Regular Physical Exercise, Stress Management Techniques, Cognitive Behavioral Therapy (CBT), Smoking Cessation, Sleep Hygiene Practices

Which Trends Are Shaping Growth In The Menopausal Disorder Treatment Market?

Leading companies in the menopausal disorder treatment market are actively developing innovative nonhormonal neurokinin 3 (NK3) receptor antagonist medications to effectively manage vasomotor symptoms without relying on hormone therapy. These advanced nonhormonal neurokinin 3 (NK3) receptor antagonist therapies are novel treatments designed to block NK3 receptors, thereby controlling menopausal symptoms without the use of hormones. For instance, in December 2023, Astellas Pharma Inc., a pharmaceutical company from Japan, secured European Commission approval for Veozah (fezolinetant), which is a non-hormonal NK3 receptor antagonist intended for the treatment of moderate to severe vasomotor symptoms (VMS) such as hot flashes and night sweats in menopausal women. This medication operates by targeting neurons in the brain’s temperature control center to reduce both the frequency and intensity of these symptoms.

Who Are The Companies Competing Within The Menopausal Disorder Treatment Market?

Major companies operating in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., TherapeuticsMD Inc.

Get The Full Menopausal Disorder Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/menopausal-disorder-treatment-global-market-report

Which Region Represents The Largest Share Of The Menopausal Disorder Treatment Market?

North America was the largest region in the menopausal disorder treatment market in 2025. The regions covered in the menopausal disorder treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Menopausal Disorder Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/menopausal-disorder-treatment-global-market-report

Browse Through More Reports Similar to the Global Menopausal Disorder Treatment Market 2026, By The Business Research Company

Menopausal Hot Flashes Market Report 2026

https://www.thebusinessresearchcompany.com/report/menopausal-hot-flashes-global-market-report

Menopause Market Report 2026

https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

Hormone Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795